These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 11473058

  • 1. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
    Kowluru RA, Tang J, Kern TS.
    Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
    [Abstract] [Full Text] [Related]

  • 2. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants.
    Kowluru RA, Kern TS, Engerman RL, Armstrong D.
    Diabetes; 1996 Sep; 45(9):1233-7. PubMed ID: 8772728
    [Abstract] [Full Text] [Related]

  • 3. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.
    Kowluru RA, Koppolu P, Chakrabarti S, Chen S.
    Free Radic Res; 2003 Nov; 37(11):1169-80. PubMed ID: 14703729
    [Abstract] [Full Text] [Related]

  • 4. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy.
    Kowluru RA, Engerman RL, Kern TS.
    Free Radic Biol Med; 1999 Feb; 26(3-4):371-8. PubMed ID: 9895229
    [Abstract] [Full Text] [Related]

  • 5. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [Abstract] [Full Text] [Related]

  • 6. Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.
    Kowluru RA, Engerman RL, Kern TS.
    Curr Eye Res; 2000 Oct; 21(4):814-9. PubMed ID: 11120572
    [Abstract] [Full Text] [Related]

  • 7. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.
    Kowluru RA, Kern TS, Engerman RL.
    Free Radic Biol Med; 1997 Oct; 22(4):587-92. PubMed ID: 9013121
    [Abstract] [Full Text] [Related]

  • 8. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy.
    Kowluru RA, Koppolu P.
    Free Radic Res; 2002 Sep; 36(9):993-9. PubMed ID: 12448825
    [Abstract] [Full Text] [Related]

  • 9. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
    Kern TS, Engerman RL.
    Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
    [Abstract] [Full Text] [Related]

  • 10. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy.
    Kowluru R, Kern TS, Engerman RL.
    Curr Eye Res; 1994 Dec; 13(12):891-6. PubMed ID: 7720397
    [Abstract] [Full Text] [Related]

  • 11. Galactose-induced retinal microangiopathy in rats.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [Abstract] [Full Text] [Related]

  • 12. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
    Berkowitz BA, Ito Y, Kern TS, McDonald C, Hawkins R.
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
    [Abstract] [Full Text] [Related]

  • 13. Retinal glutamate in diabetes and effect of antioxidants.
    Kowluru RA, Engerman RL, Case GL, Kern TS.
    Neurochem Int; 2001 Apr; 38(5):385-90. PubMed ID: 11222918
    [Abstract] [Full Text] [Related]

  • 14. Prevention of pericyte loss by trolox in diabetic rat retina.
    Ansari NH, Zhang W, Fulep E, Mansour A.
    J Toxicol Environ Health A; 1998 Jul 24; 54(6):467-75. PubMed ID: 9661912
    [Abstract] [Full Text] [Related]

  • 15. Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy.
    Kowluru RA, Engerman RL, Kern TS.
    Free Radic Res; 2000 Jan 24; 32(1):67-74. PubMed ID: 10625218
    [Abstract] [Full Text] [Related]

  • 16. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat.
    Kowluru RA.
    Curr Eye Res; 2002 Feb 24; 24(2):123-8. PubMed ID: 12187484
    [Abstract] [Full Text] [Related]

  • 17. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN, Amin R, Kennedy A, Hohman TC.
    Arch Ophthalmol; 1997 Aug 24; 115(8):1036-47. PubMed ID: 9258227
    [Abstract] [Full Text] [Related]

  • 18. Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.
    Kowluru RA, Koppolu P.
    Invest Ophthalmol Vis Sci; 2002 Oct 24; 43(10):3287-91. PubMed ID: 12356836
    [Abstract] [Full Text] [Related]

  • 19. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.
    Kowluru RA, Odenbach S.
    Diabetes; 2004 Dec 24; 53(12):3233-8. PubMed ID: 15561955
    [Abstract] [Full Text] [Related]

  • 20. Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo.
    Chen H, Tappel AL.
    Free Radic Biol Med; 1995 May 24; 18(5):949-53. PubMed ID: 7797106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.